128 related articles for article (PubMed ID: 9820553)
1. Human complement component C1q inhibits the infectivity of cell-free HTLV-I.
Ikeda F; Haraguchi Y; Jinno A; Iino Y; Morishita Y; Shiraki H; Hoshino H
J Immunol; 1998 Nov; 161(10):5712-9. PubMed ID: 9820553
[TBL] [Abstract][Full Text] [Related]
2. Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells.
Spear GT; Jiang HX; Sullivan BL; Gewurz H; Landay AL; Lint TF
AIDS Res Hum Retroviruses; 1991 Jul; 7(7):579-85. PubMed ID: 1768460
[TBL] [Abstract][Full Text] [Related]
3. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
Butko P; Nicholson-Weller A; Wessels MR
J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
[TBL] [Abstract][Full Text] [Related]
4. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
Leddy JP; Simons RL; Douglas RG
J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
[TBL] [Abstract][Full Text] [Related]
5. Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.
Blot V; Delamarre L; Perugi F; Pham D; Bénichou S; Benarous R; Hanada T; Chishti AH; Dokhélar MC; Pique C
J Cell Sci; 2004 Aug; 117(Pt 17):3983-93. PubMed ID: 15286176
[TBL] [Abstract][Full Text] [Related]
6. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.
Mills BJ; Beebe DP; Cooper NR
J Immunol; 1979 Dec; 123(6):2518-24. PubMed ID: 227957
[TBL] [Abstract][Full Text] [Related]
7. Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.
Fang D; Haraguchi Y; Jinno A; Soda Y; Shimizu N; Hoshino H
Biochem Biophys Res Commun; 1999 Aug; 261(2):357-63. PubMed ID: 10425190
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
Beebe DP; Cooper NR
J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
[TBL] [Abstract][Full Text] [Related]
9. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).
Spear GT; Lurain NS; Parker CJ; Ghassemi M; Payne GH; Saifuddin M
J Immunol; 1995 Nov; 155(9):4376-81. PubMed ID: 7594597
[TBL] [Abstract][Full Text] [Related]
10. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
[TBL] [Abstract][Full Text] [Related]
11. Humoral immunostimulation. IV. Role of complement.
Shearer WT; Atkinson JP; Frank MM; Parker CW
J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
[TBL] [Abstract][Full Text] [Related]
12. Detection of neutralizing antibodies against human T-cell leukemia virus type 1 using a cell-free infection system and polymerase chain reaction.
Haraguchi Y; Yang DW; Handa A; Shimizu N; Tanaka Y; Hoshino H
Int J Cancer; 1994 Nov; 59(3):416-21. PubMed ID: 7927951
[TBL] [Abstract][Full Text] [Related]
13. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
[TBL] [Abstract][Full Text] [Related]
14. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.
Pique C; Lagaudrière-Gesbert C; Delamarre L; Rosenberg AR; Conjeaud H; Dokhélar MC
Virology; 2000 Oct; 276(2):455-65. PubMed ID: 11040136
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
[TBL] [Abstract][Full Text] [Related]
16. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
Ying SC; Gewurz AT; Jiang H; Gewurz H
J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
[TBL] [Abstract][Full Text] [Related]
17. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
[TBL] [Abstract][Full Text] [Related]
18. Regional localization of the putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3.
Gavalchin J; Fan N; Waterbury PG; Corbett E; Faldasz BD; Peshick SM; Poiesz BJ; Papsidero L; Lane MJ
Virology; 1995 Sep; 212(1):196-203. PubMed ID: 7676629
[TBL] [Abstract][Full Text] [Related]
19. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
[TBL] [Abstract][Full Text] [Related]
20. Pseudotype viruses bearing envelope antigens of Japanese isolates of human T-cell leukemia viruses type I.
Hoshino H; Weiss RA; Clapham P; Miwa M; Miyoshi I; Yoshida M; Sugimura T
Princess Takamatsu Symp; 1984; 15():159-64. PubMed ID: 6152758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
